Home
Regulatory UpdatesSep 4, 2026•1 min read

Gore VIABAHN® Device Quality Issue Identified

By the PharmaCountry team

Gore discovered some VIABAHN® devices were processed on equipment outside validated range, risking incorrect distal tip bonding.

Health Canada has issued an alert after Gore identified, through quality‑control testing, that a subset of its VIABAHN® endoprosthesis devices were processed using equipment that was operating outside the validated range. This condition could potentially lead to an incorrect bonding location of the distal tip onto the delivery catheter. Manufacturers and users are advised to review the affected product batches and follow any further guidance from Health Canada regarding corrective actions or product handling.

Compiled by the PharmaCountry team · Source: Health Canada

More articles

View all insights